COLLEGIUM PHARMACEUTICAL, INC (COLL) Retained Earnings (Accumulated Deficit) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Collegium Pharmaceutical, Inc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2014 to 2024.
  • Collegium Pharmaceutical, Inc Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$205 M, a 31.2% increase year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$205 M +$93.3 M +31.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$233 M +$48.2 M +17.1% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 -$265 M +$9.02 M +3.29% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$286 M -$11.2 M -4.06% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$299 M -$29.4 M -10.9% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 -$281 M -$25 M -9.75% Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$274 M -$42.8 M -18.5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$275 M -$35.2 M -14.7% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$269 M +$42.8 M +13.7% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 -$256 M +$76.8 M +23.1% Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$231 M +$109 M +32% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$239 M +$112 M +31.9% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$312 M +$47.3 M +13.1% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$333 M +$26.8 M +7.43% Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$340 M +$17.6 M +4.92% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$351 M +$198 K +0.06% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 -$359 M -$12.6 M -3.62% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$360 M -$22.7 M -6.74% Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$358 M -$11.4 M -3.3% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 -$352 M -$21.8 M -6.62% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$347 M -$30.2 M -9.53% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 -$337 M -$39.1 M -13.1% Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$346 M -$65.6 M -23.4% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 -$330 M -$62.4 M -23.3% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 -$317 M -$70.4 M -28.6% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 -$298 M -$74.9 M -33.5% Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$281 M -$85 M -43.5% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$267 M -$98.2 M -58% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 -$246 M -$102 M -70.2% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$223 M -$94.2 M -73% Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$196 M -$76.1 M -63.7% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 -$169 M -$59.1 M -53.6% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 -$145 M -$39.2 M -37.2% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 -$129 M -$27.3 M -26.8% Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$119 M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 -$110 M Jun 30, 2015 10-Q 2015-08-12
Q1 2015 -$105 M Mar 31, 2015 10-Q/A 2015-07-17
Q4 2014 -$102 M Dec 31, 2014 10-K 2016-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.